Impact of quality of life to overall productivity impairment and activity impairment of patients with systemic lupus erythematosus

JRCT ID: jRCT1030210647

Registered date:06/03/2022

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Systemic lupus erythematosus
• Date of first enrollment: 25/03/2022
• Target sample size: 207
• Study type: Observational
• Intervention(s): -

Outcome(s)

• Primary Outcome: Assess the residual burden remaining after meet LLDAS.
• Secondary Outcome: Relationship between Activity Impairment and PROs in 2 groups (non LLDAS/LLDAS).

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1. Patients with informed consent
2. Patients with Age >= 18 years old
3. Patients diagnosed with SLE >= 16 years old
4. Patients diagnosed as systemic lupus erythematosus according to the revised 1997 American College of Rheumatology (ACR) or SLICC criteria.

Exclude criteria

1. Patients with a diagnosis of SLE within 12 months.
2. Patients who are judged to need hospitalization when unscheduled visit.
3. Patient who, in the opinion of the investigator, is unlikely to comply with the protocol or is unsuitable for any other reason.

Related Information

• Primary Sponsor: Tanaka Michio